Hirofumi Ochi

2.5k total citations
89 papers, 1.8k citations indexed

About

Hirofumi Ochi is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Hirofumi Ochi has authored 89 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 28 papers in Immunology and 24 papers in Neurology. Recurrent topics in Hirofumi Ochi's work include Multiple Sclerosis Research Studies (34 papers), Peripheral Neuropathies and Disorders (13 papers) and T-cell and B-cell Immunology (12 papers). Hirofumi Ochi is often cited by papers focused on Multiple Sclerosis Research Studies (34 papers), Peripheral Neuropathies and Disorders (13 papers) and T-cell and B-cell Immunology (12 papers). Hirofumi Ochi collaborates with scholars based in Japan, United States and Israel. Hirofumi Ochi's co-authors include Jun‐ichi Kira, Manabu Osoegawa, Motozumi Minohara, Howard L. Weiner, Dan Frenkel, Hiroyuki Murai, Takuya Matsushita, Hiroki Ishikawa, Ruth Maron and Kazuo Fujihara and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hirofumi Ochi

87 papers receiving 1.8k citations

Peers

Hirofumi Ochi
Mariko Kita United States
Amanda Cox United States
John Lindsey United States
Til Menge Germany
Staley A. Brod United States
Mariko Kita United States
Hirofumi Ochi
Citations per year, relative to Hirofumi Ochi Hirofumi Ochi (= 1×) peers Mariko Kita

Countries citing papers authored by Hirofumi Ochi

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Ochi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Ochi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Ochi more than expected).

Fields of papers citing papers by Hirofumi Ochi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Ochi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Ochi. The network helps show where Hirofumi Ochi may publish in the future.

Co-authorship network of co-authors of Hirofumi Ochi

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Ochi. A scholar is included among the top collaborators of Hirofumi Ochi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Ochi. Hirofumi Ochi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochi, Hirofumi, Satoru Nakamura, & Jin Nakahara. (2025). B cell depletion as a therapeutic strategy for neuromyelitis optica spectrum disorder: rationale, evidence, and challenges. Frontiers in Immunology. 16. 1635989–1635989.
2.
Yoshitomi, Hiroyuki, Kimitoshi Kimura, Masaki Takata, et al.. (2025). CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica. Brain. 148(8). 2995–3010. 3 indexed citations
3.
Takei, Satoko, Masayuki Ochi, Sayaka Matsumoto, et al.. (2024). Frailty and aging are associated with cognitive decline and dermal advanced glycation end-product accumulation in older Japanese men. SHILAP Revista de lepidopterología. 1(4). 100071–100071. 1 indexed citations
4.
Watanabe, Mitsuru, Noriko Isobe, Masaaki Niino, et al.. (2024). Prevalence of, and Disability Due to, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Japan by the Fifth Nationwide Survey. Neurology. 103(10). e209992–e209992. 3 indexed citations
5.
Ashida, Shinji, Hirofumi Ochi, Kimitoshi Kimura, et al.. (2021). Immune Skew of Circulating Follicular Helper T Cells Associates With Myasthenia Gravis Severity. Neurology Neuroimmunology & Neuroinflammation. 8(2). 35 indexed citations
6.
Miura, Shiroh, Masayuki Ochi, Takuya Matsuda, et al.. (2021). Unilateral lower limb atrophy associated with glomus tumors: a case report. Journal of Medical Case Reports. 15(1). 8–8. 1 indexed citations
7.
Yamasaki, Ryo, Tomomi Yonekawa, Koji Shinoda, et al.. (2019). A case of overlapping adult‐onset linear scleroderma and Parry‐Romberg syndrome presenting with widespread ipsilateral neurogenic involvement. Neuropathology. 40(1). 109–115. 3 indexed citations
8.
Hiraoka, Atsushi, Takashi Kumada, Masashi Hirooka, et al.. (2017). A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade. Hepatology Research. 48(3). E61–E67. 17 indexed citations
9.
Kikuchi, Hiromi, Nobuhiro Mifune, Masaaki Niino, et al.. (2013). Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis. BMC Neurology. 13(1). 10–10. 20 indexed citations
10.
Huang, Jian, Satoshi Yoshimura, Noriko Isobe, et al.. (2013). A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese. Multiple Sclerosis Journal. 19(13). 1696–1703. 5 indexed citations
11.
Matsushita, Takuya, Takashi Matsuoka, Noriko Isobe, et al.. (2009). Association of the HLA‐DPB1*0501 allele with anti‐aquaporin‐4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens. 73(2). 171–176. 98 indexed citations
12.
Zhang, Xingmin, Jayagopala Reddy, Hirofumi Ochi, et al.. (2006). Recovery from experimental allergic encephalomyelitis is TGF-β dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells. International Immunology. 18(4). 495–503. 74 indexed citations
13.
Osoegawa, Manabu, Masaaki Niino, Hirofumi Ochi, et al.. (2004). Platelet-activating factor acetylhydrolase gene polymorphism and its activity in Japanese patients with multiple sclerosis. Journal of Neuroimmunology. 150(1-2). 150–156. 12 indexed citations
14.
Yamada, Takeshi, Yasumasa Ohyagi, Nobue Shinnoh, et al.. (2003). Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model. Journal of the Neurological Sciences. 218(1-2). 91–97. 17 indexed citations
15.
Ochi, Hirofumi, Manabu Osoegawa, Motozumi Minohara, et al.. (2002). Increased IL-13 but not IL-5 production by CD4-positive T cells and CD8-positive T cells in multiple sclerosis during relapse phase. Journal of the Neurological Sciences. 201(1-2). 45–51. 25 indexed citations
16.
Ohyagi, Yasumasa, Isao Inoue, Hirofumi Ochi, et al.. (2002). A patient with delayed posthypoxic demyelination: a case report of hyperbaric oxygen treatment. Clinical Neurology and Neurosurgery. 104(4). 311–314. 2 indexed citations
17.
Minohara, Motozumi, Hirofumi Ochi, Sho Matsushita, et al.. (2001). Differences between T‐cell reactivities to major myelin protein‐derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls. Tissue Antigens. 57(5). 447–456. 23 indexed citations
18.
Horiuchi, Izumi, et al.. (2001). Th2 shift in mononeuritis multiplex and increase of Th2 cells in chronic inflammatory demyelinating polyneuropathy: an intracellular cytokine analysis. Journal of the Neurological Sciences. 193(1). 49–52. 18 indexed citations
19.
Ochi, Hirofumi & Takeshi Watanabe. (2000). Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity. International Immunology. 12(10). 1417–1423. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026